Abstract:
Objective: To explore the surgical efficacy of transrectal closed repair plus rectal submucosal injection of sclerosing agent on patients with rectocele.
Methods: Twenty cases of rectocele were treated with combined therapy of transrectal repair and rectal submucosal injection of sclerosing agent.
Results: Eighteen of the 20 cases were cured and 2 cases responded well.No remarkable sequelae were observed in the follow-up of 0.5-2.0 years.
Conclusions: Combination therapy of transrectal closed repair and rectal submucosal injection of sclerosing agent is safe and effective for treatment of rectocele.